In this retrospective study, we aimed to analyze the demographics and baseline clinical and laboratory characteristics of patients with progressive COVID-19 and those with stable COVID-19 and evaluate the capability of CRP/Alb ratio in predicting the risk of progression to critical illness or death in the early stages of severe COVID-19. This evidence concerns the gene CRP and COVID-19.